Asthma and COVID-19: What do we know now
Alexzandra Hughes-Visentin, Anthea B. Mahesan Paul
2020Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine35 citationsDOIOpen Access PDF
Abstract
The COVID-19 pandemic has presented challenges in symptomology identification, diagnosis, management and follow-up in common respiratory diseases, and in particular asthma. Research is rapidly ongoing to try and understand how the SARS-CoV-2 virus affects individuals with asthma, as well as, how underlying asthma affects Covid-19 risk, symptomology and prognosis. In light of this unique medical challenge, clinicians are faced with case-by-case based decisions to implement or continue current asthma therapy. This review will discuss the current literature regarding asthma and COVID-19 based on best available evidence at this time (See box 1).
Topics & Concepts
AsthmaCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineIntensive care medicine2019-20 coronavirus outbreakIdentification (biology)Asthma managementDiseaseImmunologyVirologyPathologyInfectious disease (medical specialty)BotanyBiologyOutbreakCOVID-19 Clinical Research StudiesChronic Obstructive Pulmonary Disease (COPD) ResearchRespiratory Support and Mechanisms